SubQperior: An Innovative and Superior Syngeneic Model System
Scientist
Date: March 18. Time: 10:30 AM EST.
The novel SubQperior tumor models overcome common challenges of subcutaneous tumor models based on improved tumor cell implantation technique. SubQperior efficacy studies provide outstanding statistical value due to homogenous tumor growth and absence of ulceration issues. In this webinar, we present how SubQperior syngeneic models are used at Reaction Biology to advance immune-oncology drug development programs to create efficacious immunotherapies. All oncology program leaders are welcome to take part in the webinar.